Deutsche Bank’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-16,750
| Closed | -$804K | – | 4483 |
|
|
2020
Q1 | $804K | Sell |
16,750
-36,686
| -69% | -$1.76M | ﹤0.01% | 2211 |
|
|
2019
Q4 | $2.51M | Buy |
53,436
+17,857
| +50% | +$838K | ﹤0.01% | 1827 |
|
|
2019
Q3 | $839K | Sell |
35,579
-16,511
| -32% | -$389K | ﹤0.01% | 2387 |
|
|
2019
Q2 | $1.57M | Sell |
52,090
-145,651
| -74% | -$4.38M | ﹤0.01% | 2547 |
|
|
2019
Q1 | $4.43M | Buy |
197,741
+131,308
| +198% | +$2.94M | ﹤0.01% | 1941 |
|
|
2018
Q4 | $1.21M | Sell |
66,433
-30,830
| -32% | -$561K | ﹤0.01% | 2732 |
|
|
2018
Q3 | $1.76M | Buy |
97,263
+6,109
| +7% | +$111K | ﹤0.01% | 2926 |
|
|
2018
Q2 | $907K | Sell |
91,154
-134,798
| -60% | -$1.34M | ﹤0.01% | 3462 |
|
|
2018
Q1 | $1.2M | Buy |
225,952
+199,527
| +755% | +$1.06M | ﹤0.01% | 3168 |
|
|
2017
Q4 | $224K | Buy |
26,425
+921
| +4% | +$7.81K | ﹤0.01% | 3828 |
|
|
2017
Q3 | $370K | Sell |
25,504
-1,661
| -6% | -$24.1K | ﹤0.01% | 3472 |
|
|
2017
Q2 | $508K | Buy |
27,165
+8,682
| +47% | +$162K | ﹤0.01% | 3356 |
|
|
2017
Q1 | $392K | Sell |
18,483
-10,152
| -35% | -$215K | ﹤0.01% | 3125 |
|
|
2016
Q4 | $432K | Buy |
+28,635
| New | +$432K | ﹤0.01% | 3175 |
|